Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Sarcoma 48Lymphoma 34Lymphoma, Large B-Cell, Diffuse 32Lymphoma, Non-Hodgkin 23Osteosarcoma 21Hodgkin Disease 17Testicular Neoplasms 16Burkitt Lymphoma 13Testicular Germ Cell Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Ovarian Neoplasms 12Teratoma 9Neuroectodermal Tumors, Primitive, Peripheral 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Follicular 9Neuroblastoma 8Lymphoma, Large-Cell, Anaplastic 8Central Nervous System Neoplasms 8Recurrence 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell 7Leukemia 7Endodermal Sinus Tumor 7Seminoma 6Rhabdomyosarcoma 6Lymphoma, B-Cell, Marginal Zone 6Breast Neoplasms 6Small Cell Lung Carcinoma 5Neoplasms, Germ Cell and Embryonal 5Neoplasms 5

Interventions

fludarabine phosphate 16Peripheral Blood Stem Cell Transplantation 16Cyclophosphamide 12Whole-Body Irradiation 11Mycophenolic Acid 11Cyclosporine 11Etoposide 6Tacrolimus 5Methotrexate 5Filgrastim 5Antilymphocyte Serum 5Rituximab 4Radiotherapy 4Methylprednisolone 4Melphalan 4Busulfan 4Bortezomib 4Transplantation 3Thiotepa 3Therapeutics 3Prednisone 3Epoetin Alfa 3Darbepoetin alfa 3Alemtuzumab 3thymoglobulin 2ruxolitinib 2fludarabine 2Thalidomide 2Psychiatric Rehabilitation 2Pentetic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Large Granular Lymphocytic × Ifosfamide × Clear all
NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

New York Medical College

Phase EARLY_PHASE1 Recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡